Inventiva reported its unaudited financial results for the first half of 2025, with cash and cash equivalents, including short-term deposits, totaling €146.7 million as of June 30, 2025. This compares to €96.6 million in cash and cash equivalents at the end of 2024.
Revenues for the first half of 2025 amounted to €4.5 million, primarily from a $10 million milestone payment and $5 million in credit notes from CTTQ, following the settlement of the second tranche of structured financing. The company's net loss for the first half of 2025 was (€175.9) million, a significant increase from (€49.0) million in the first half of 2024, largely due to a (€113.2) million net financial loss from non-cash IFRS treatment of derivative instruments.
Net cash used in operating activities for H1 2025 was (€53.7) million, while R&D expenses decreased by 4% to €44.9 million. With the €115.6 million gross proceeds from the second tranche of structured financing received in May 2025 and the $10 million CTTQ milestone payment received in July 2025, Inventiva estimates its cash runway will extend until the end of the third quarter of 2026.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.